Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver
Obesity can be associated with an increased risk of metabolic complications. Here, the authors show that adipocyte-specific ablation of the phosphatase PHLPP2 improves glucose homeostasis in high-fat diet fed obese mice, and that this may be due at least in part to PHLPP2 dephosphorylation of HSL.
Saved in:
Main Authors: | KyeongJin Kim, Jin Ku Kang, Young Hoon Jung, Sang Bae Lee, Raffaela Rametta, Paola Dongiovanni, Luca Valenti, Utpal B. Pajvani |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/fbedf8ee43a14e308e77f09b74b4c302 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mTORC1-independent Raptor prevents hepatic steatosis by stabilizing PHLPP2
by: KyeongJin Kim, et al.
Published: (2016) -
Obesity, adipocyte hypertrophy, fasting glucose, and resistin are potential contributors to nonalcoholic fatty liver disease in South Asian women
by: Albracht-Schulte K, et al.
Published: (2019) -
Advanced lipodystrophy reverses fatty liver in mice lacking adipocyte hormone-sensitive lipase
by: Laura Pajed, et al.
Published: (2021) -
Maternal tadalafil therapy for fetal growth restriction prevents non-alcoholic fatty liver disease and adipocyte hypertrophy in the offspring
by: Takuya Kawamura, et al.
Published: (2021) -
Obesity and nonalcoholic fatty liver disease: current perspectives
by: Sarwar R, et al.
Published: (2018)